Connect with us

Hi, what are you looking for?


IBM Q1 results suggest it’s a ‘bastion of stability’

IBM (NYSE: IBM), on Wednesday, reported better-than-expected earnings for its first financial quarter. Its shares still gained only slightly in extended trading.

Analyst reacts to IBM’s Q1 earnings report

Investors are perhaps focusing more on a marginal miss in terms of revenue.

The tech behemoth also talked of some weakness in its consulting business. Still, Amit Daryanani of Evercore ISI said on CNBC’s “Closing Bell: Overtime”:

These numbers validate IBM being this bastion of stability when there’s macro turmoil. We were surprised by double-digit constant currency growth they had in Red Hat.

His $150 price target on IBM stock suggests an 18% upside from here.

IBM’s guidance for the future

On the plus side, IBM forecasts between 3.0% and 5.0% growth in its revenue this year. In comparison, analysts were at 3.6%.

The Armonk-headquartered firm sees $10.5 billion in free cash flow for the full year – up from $9.3 billion in 2022. Daryanani added:

The fact that they’re comfortable sticking with $10.5 billion free cash flow is fairly impressive – all the more impressive given the macro and IT spent worries.

CEO Arvind Krishna also confirmed today that the company isn’t developing consumer-facing AI products. For the year, IBM stock is down about 10% at writing.

IBM Q1 financial highlights

Net income printed at $927 million versus year-ago $733 million

Per-share earnings also climbed from 82 cents to $1.02

Adjusted EPS came in at $1.36 as per the earnings press release

Revenue went up only 0.4% year-over-year to $14.25 billion

FactSet consensus was $1.26 a share on $14.35 billion revenue

Revenue from infrastructure, consulting, and software businesses climbed 3.7%, 2.8%, and 2.6%, respectively – all roughly in line with Street expectations.

The post IBM Q1 results suggest it’s a ‘bastion of stability’ appeared first on Invezz.

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Latest News

    Rep. Jennifer Wexton (D-Va.) announced on Tuesday that she has been diagnosed with Parkinson’s Disease. “If there’s one thing that Democrats and Republicans can...

    Latest News

    After Dianne Feinstein announced she’d contracted the shingles in early March, her staff said she planned to return to the Senate within a matter...


    A U.S. District Court judge has ruled that Elizabeth Holmes, founder and CEO of the disgraced blood-testing company Theranos, cannot remain free on bail...

    Latest News

    SEOUL, South Korea — When a group of American lawmakers arrived in South Korea for meetings with government and military officials, President Yoon Suk-yeol...

    Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2022 All Rights Reserved.